Management of Menopause and Osteoporosis Treatments questions and answers

Management of Menopause and
Osteoporosis Treatments questions and
answers
Menopause - ANSWER>>Natural cessation of menstruation, typically around age
50.

Postmenopause - ANSWER>>Period after menopause, increased risk of
osteoporosis.

Osteoporosis - ANSWER>>Condition characterized by weakened bones and
increased fracture risk.

Bisphosphonates - ANSWER>>Medications that inhibit bone resorption to treat
osteoporosis.

Zoledronic Acid - ANSWER>>Intravenous bisphosphonate for osteoporosis
treatment and prevention.

Renal Contraindication - ANSWER>>Creatinine clearance < 35 mL/min prohibits
bisphosphonate use.

Gastrointestinal Side Effects - ANSWER>>Common adverse effects of
bisphosphonates include nausea and pain.

Osteonecrosis of the Jaw - ANSWER>>Rare condition linked to bisphosphonate
use, especially in cancer patients.

Atypical Fractures - ANSWER>>Rare fractures associated with long-term
bisphosphonate therapy.

Calcitonin - ANSWER>>Hormone that inhibits osteoclast activity and bone
resorption.

Salmon Calcitonin - ANSWER>>Most potent calcitonin form, available intranasally
or subcutaneously.